Gridiron BioNutrients, Inc. (GMVP)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Gridiron BioNutrients, Inc. (GMVP) trades at $1.03 with AI Score 56/100 (Grade B). Gridiron BioNutrients, Inc. operates in the cannabidiol (CBD) market, developing and selling various CBD products through its online platform. Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for GMVP: GMVP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GMVP against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
GMVP: 2/6 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Gridiron BioNutrients, Inc. (GMVP) Healthcare & Pipeline Overview
Gridiron BioNutrients, Inc. is a cannabidiol (CBD) product developer and online retailer, offering a range of CBD-infused products such as capsules, oils, and beverages. Operating in the specialty and generic drug manufacturing sector, the company aims to capture a segment of the growing CBD market through its online platform under the Gridiron BioNutrients and Gridiron MVP brands.
What Is the Investment Thesis for GMVP?
Gridiron BioNutrients, Inc. presents a speculative investment opportunity within the high-growth CBD market. The company's online sales model and diverse product range offer potential for revenue expansion. However, the company's financial performance and limited information availability due to its OTC listing require careful consideration. Key value drivers include successful product innovation, effective marketing strategies, and favorable regulatory developments in the CBD industry. The company's small size and limited resources pose risks to its ability to compete effectively with larger, more established players. The P/E ratio of -0.00 indicates the company is not currently profitable. The beta of 1.47 suggests higher volatility compared to the overall market. Investors should carefully weigh the potential rewards against the inherent risks associated with investing in a small, OTC-listed company in a rapidly evolving industry.
Based on FMP financials and quantitative analysis
GMVP Key Highlights
- Gridiron BioNutrients, Inc. operates in the rapidly growing cannabidiol (CBD) market, offering potential for high revenue growth.
- The company's online sales platform provides direct access to consumers, reducing reliance on traditional retail channels.
- A diverse product range, including capsules, oils, and beverages, caters to a broad customer base seeking various CBD applications.
- The company's small size and limited resources may pose challenges to scaling operations and competing with larger players.
- The company's P/E ratio of -0.00 indicates it is not currently profitable, requiring investors to focus on future growth potential.
Who Are GMVP's Competitors?
GMVP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATHJF Antisense Therapeutics Limited | $0.01 | -76.00% | $19.64M | 57 |
| BFFTF Biofrontera AG | $0.33 | -95.24% | $19.35M | 46 |
| CHBRF Chill Brands Group PLC | $0.05 | +48.84% | $24.45M | 38 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | 26M | 63 |
| GRAMF TPCO Holding Corp. | $0.16 | -15.36% | $20.12M | 42 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GMVP's Key Strengths?
- Online sales platform provides direct access to consumers.
- Diverse product range caters to a broad customer base.
- Established brand names: Gridiron BioNutrients and Gridiron MVP.
- Focus on the growing CBD market.
What Are GMVP's Weaknesses?
- Small size and limited resources.
- Reliance on a single online sales channel.
- Limited brand awareness compared to larger competitors.
- OTC listing may limit investor interest.
What Could Drive GMVP Stock Higher?
- Potential regulatory changes in the CBD industry could create new market opportunities.
- Increasing consumer awareness of the potential therapeutic benefits of CBD.
- Expansion of the company's product line to include new CBD-infused products.
- Strategic partnerships with established companies in the healthcare or wellness industry.
- Potential uplisting to a higher tier of the OTC market or a major exchange.
What Are the Key Risks for GMVP?
- Intense competition in the CBD market could erode market share.
- Evolving regulatory landscape for CBD products could create compliance challenges.
- Negative publicity related to CBD safety could damage the company's reputation.
- Fluctuations in the price of hemp and CBD原料 could impact profitability.
- Limited financial resources may hinder the company's ability to scale operations.
What Are the Growth Opportunities for GMVP?
- Expansion into New Therapeutic Areas: Gridiron BioNutrients can explore developing CBD-based products targeting specific health conditions, such as anxiety, sleep disorders, and chronic pain. The market for CBD products targeting these conditions is substantial and growing rapidly. By focusing on specific therapeutic applications, Gridiron BioNutrients can differentiate itself from competitors and capture a larger share of the market. This expansion requires investment in research and development to formulate effective and safe CBD products tailored to specific health needs. The timeline for developing and launching new therapeutic products is estimated at 12-24 months, depending on regulatory requirements and clinical testing.
- Geographic Market Expansion: Gridiron BioNutrients can expand its online sales operations to new geographic markets, both domestically and internationally. The demand for CBD products is growing globally, presenting significant opportunities for companies with established online platforms. Expanding into new markets requires adapting product offerings to local regulations and consumer preferences. This expansion can be achieved through partnerships with local distributors or by establishing a direct online presence in new markets. The timeline for geographic expansion is estimated at 6-12 months per new market, depending on regulatory approvals and market entry strategies.
- Strategic Partnerships and Acquisitions: Gridiron BioNutrients can pursue strategic partnerships or acquisitions to expand its product portfolio, distribution network, and market reach. Partnering with established companies in the healthcare or wellness industry can provide access to new customers and distribution channels. Acquiring smaller CBD product manufacturers can add new products and technologies to Gridiron BioNutrients' existing portfolio. These partnerships and acquisitions can accelerate growth and enhance the company's competitive position. The timeline for strategic partnerships and acquisitions varies depending on the complexity of the deals and regulatory approvals.
- Development of Innovative Product Formulations: Gridiron BioNutrients can invest in research and development to create innovative CBD product formulations that offer enhanced bioavailability, efficacy, and convenience. This includes exploring new delivery methods, such as nanoemulsions, liposomes, and transdermal patches. Developing innovative product formulations can differentiate Gridiron BioNutrients from competitors and attract customers seeking advanced CBD solutions. The timeline for developing and launching new product formulations is estimated at 12-18 months, depending on the complexity of the formulations and clinical testing.
- Focus on Branding and Marketing: Gridiron BioNutrients can strengthen its brand identity and marketing efforts to increase brand awareness and customer loyalty. This includes investing in targeted advertising campaigns, social media marketing, and influencer collaborations. Building a strong brand can differentiate Gridiron BioNutrients from competitors and attract customers in a crowded market. The timeline for strengthening branding and marketing efforts is ongoing, requiring continuous investment and adaptation to changing market trends.
What Opportunities Does GMVP Have?
- Expansion into new therapeutic areas.
- Geographic market expansion.
- Strategic partnerships and acquisitions.
- Development of innovative product formulations.
What Threats Does GMVP Face?
- Intense competition in the CBD market.
- Evolving regulatory landscape for CBD products.
- Potential for negative publicity related to CBD safety.
- Fluctuations in the price of hemp and CBD原料.
What Are GMVP's Competitive Advantages?
- Established online sales platform provides direct access to consumers.
- Diverse product range caters to a broad customer base.
- Brand recognition through the Gridiron BioNutrients and Gridiron MVP names.
What Does GMVP Do?
Founded in 2014 and based in Scottsdale, Arizona, Gridiron BioNutrients, Inc. is a developer, marketer, and seller of cannabidiol (CBD) products. The company's inception was driven by the increasing consumer interest in alternative health and wellness solutions, particularly those derived from hemp and cannabis. Gridiron BioNutrients offers a diverse portfolio of CBD products, including capsules, oils, gummies, concentrates, water, beverages, hemp tinctures, and salves. These products are marketed under the Gridiron BioNutrients and Gridiron MVP brands, primarily through the company's online platform. The company focuses on catering to a broad customer base seeking the potential therapeutic benefits of CBD, such as pain relief, anxiety reduction, and improved sleep. By offering a variety of product formats, Gridiron BioNutrients aims to provide consumers with convenient and accessible options for incorporating CBD into their daily routines. The company's online sales strategy allows it to reach a national audience, bypassing the limitations of brick-and-mortar retail. Gridiron BioNutrients operates within the specialty and generic drug manufacturing industry, specifically targeting the burgeoning CBD market. As the regulatory landscape for CBD continues to evolve, the company navigates the challenges and opportunities associated with this emerging sector.
What Products and Services Does GMVP Offer?
- Develops cannabidiol (CBD) products.
- Markets CBD products through an online platform.
- Sells capsules containing CBD.
- Offers CBD oil in various concentrations.
- Provides CBD-infused gummies.
- Produces CBD concentrates.
- Sells CBD-infused water and beverages.
- Offers hemp tinctures and salves containing CBD.
How Does GMVP Make Money?
- Develops and manufactures a range of CBD products.
- Sells products directly to consumers through its online platform.
- Generates revenue through online sales of CBD products.
What Industry Does GMVP Operate In?
Gridiron BioNutrients operates within the rapidly expanding cannabidiol (CBD) market, a segment of the broader healthcare and wellness industry. The CBD market has experienced significant growth in recent years, driven by increasing consumer awareness of the potential therapeutic benefits of CBD and the loosening of regulations surrounding hemp-derived products. However, the market is also characterized by intense competition, with numerous companies vying for market share. Competitors range from large pharmaceutical companies exploring CBD-based therapies to smaller, specialized CBD product manufacturers. Gridiron BioNutrients aims to differentiate itself through its diverse product range and online sales strategy. The global CBD market is projected to reach billions of dollars in the coming years, presenting both opportunities and challenges for companies like Gridiron BioNutrients.
Who Are GMVP's Key Customers?
- Individuals seeking the potential therapeutic benefits of CBD.
- Consumers looking for alternative health and wellness solutions.
- Customers interested in pain relief, anxiety reduction, and improved sleep.
- Individuals seeking convenient and accessible CBD products.
Company Profile
Gridiron BioNutrients, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Scottsdale, US. GMVP has traded publicly since 2017.
GMVP Valuation & Market Position
Relative to its peer group, GMVP's quantitative score of 56/100 is roughly in line with the peer average of 49/100.
GMVP Financials
Bull Case vs Bear Case
Bull Case
- Online sales platform provides direct access to consumers.
- Diverse product range caters to a broad customer base.
- Established brand names: Gridiron BioNutrients and Gridiron MVP.
- Focus on the growing CBD market.
Bear Case
- Small size and limited resources.
- Reliance on a single online sales channel.
- Limited brand awareness compared to larger competitors.
- OTC listing may limit investor interest.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
GMVP Latest News
No recent news available for GMVP.
GMVP Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GMVP.
Price Targets
Wall Street price target analysis for GMVP.
GMVP MoonshotScore
What does this score mean?
The MoonshotScore rates GMVP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
GMVP OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Gridiron BioNutrients, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier are often early-stage ventures, shell companies, or companies with distressed financials. Investing in OTC Other stocks carries significant risks due to the limited information available and the potential for fraud or manipulation. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to stringent listing requirements or regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in GMVP.
- Low trading volume and wide bid-ask spreads can lead to price volatility and difficulty in executing trades.
- The OTC Other tier designation indicates a higher risk of fraud or manipulation.
- The company's small size and limited resources may hinder its ability to compete effectively.
- The evolving regulatory landscape for CBD products adds uncertainty to the company's future prospects.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's competitive position in the CBD market.
- Evaluate the company's compliance with relevant regulations.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor before investing.
- Confirm the legitimacy of the company's business operations.
- The company has been in operation since 2014.
- The company offers a range of CBD products through its online platform.
- The company markets its products under the Gridiron BioNutrients and Gridiron MVP brands.
GMVP Healthcare Stock FAQ
What does Gridiron BioNutrients, Inc. do?
Gridiron BioNutrients, Inc. develops, markets, and sells a variety of cannabidiol (CBD) products through its online platform. The company offers capsules, oils, gummies, concentrates, water, beverages, hemp tinctures, and salves under the Gridiron BioNutrients and Gridiron MVP brands. By focusing on the growing CBD market, Gridiron BioNutrients aims to provide consumers with diverse and accessible options for incorporating CBD into their daily routines. The company operates within the specialty and generic drug manufacturing industry, specifically targeting the burgeoning CBD market.
What do analysts say about GMVP stock?
As of 2026-03-18, there is no readily available analyst coverage for Gridiron BioNutrients, Inc. (GMVP) due to its OTC listing and limited market capitalization. Key valuation metrics, such as price targets and earnings estimates, are not widely available. Investors should conduct their own thorough research and due diligence before making any investment decisions. Factors to consider include the company's financial performance, competitive position, and the evolving regulatory landscape for CBD products. The absence of analyst coverage underscores the speculative nature of this investment.
What are the main risks for GMVP?
Investing in Gridiron BioNutrients, Inc. (GMVP) carries significant risks due to its OTC listing, limited financial disclosure, and the evolving regulatory landscape for CBD products. The company faces intense competition from larger, more established players in the CBD market. Fluctuations in the price of hemp and CBD原料 could impact profitability. Negative publicity related to CBD safety could damage the company's reputation. The company's small size and limited resources may hinder its ability to scale operations and compete effectively. Investors should carefully consider these risks before investing in GMVP.
What are the key growth opportunities for GMVP in healthcare?
Unknown
How does Gridiron BioNutrients, Inc. navigate regulatory approval processes?
As a developer and marketer of CBD products, Gridiron BioNutrients, Inc. must navigate a complex and evolving regulatory landscape. The company must comply with regulations related to the manufacturing, labeling, and marketing of CBD products. This includes adhering to guidelines set forth by the FDA and other regulatory agencies. Gridiron BioNutrients must also monitor changes in regulations and adapt its business practices accordingly. The company's ability to navigate these regulatory challenges will be critical to its long-term success. However, specific details regarding Gridiron BioNutrients, Inc.'s FDA/EMA regulatory track record, pending approvals, and compliance strategy are currently Unknown.
What are the key factors to evaluate for GMVP?
Gridiron BioNutrients, Inc. (GMVP) holds an AI score of 56/100 (moderate). Not financial advice.
How frequently does GMVP data refresh on this page?
GMVP prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GMVP's recent stock price performance?
Gridiron BioNutrients, Inc. (GMVP) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Online sales platform provides direct access to consumers. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing.
- Financial data may not be fully reliable.
- AI analysis pending for GMVP.